These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3529000

  • 1. [Effect on lipids, lipoproteins and apoproteins of labetalol prescribed in doses of 400 mg/day in hypertensive patients. Double-blind versus placebo study].
    Rouffy J, Bakir R, Chanu B, Djian F, Goy-Loeper J, Henry Amar M, Renon D, Pappo M.
    Pathol Biol (Paris); 1986 Apr; 34(4):253-8. PubMed ID: 3529000
    [Abstract] [Full Text] [Related]

  • 2. Effect of prazosin and propranolol on lipoproteins of hypertensive patients.
    Hurt E, Velasco M, Silva H, Camejo G.
    Biomed Biochim Acta; 1987 Apr; 46(1):111-8. PubMed ID: 3107546
    [Abstract] [Full Text] [Related]

  • 3. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
    Lijnen P, Celis H, Desager JP, Fagard R.
    J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R.
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [Abstract] [Full Text] [Related]

  • 5. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P, Echevaría-Vázquez D, Petrov V.
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
    [Abstract] [Full Text] [Related]

  • 6. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G, Mas R, Fernández L, Illnait J, Gámez R, Alvarez E.
    Int J Clin Pharmacol Res; 2001 Mar; 21(1):43-57. PubMed ID: 11708574
    [Abstract] [Full Text] [Related]

  • 7. [Arterial hypertension in the elderly. Double-blind study versus placebo of the efficacy and tolerability of an alpha-beta blocker: labetalol].
    Forette F, Henry-Amar M, d'Allens H, Hervy MP, Bouchacourt P, Henry JF, Pappo M.
    Ann Cardiol Angeiol (Paris); 1987 Feb; 36(2):103-7. PubMed ID: 3827157
    [Abstract] [Full Text] [Related]

  • 8. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Feb; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 10. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L.
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [Abstract] [Full Text] [Related]

  • 11. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
    Lacourcière Y, Gagné C.
    J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
    [Abstract] [Full Text] [Related]

  • 12. [Effect of beta blockers with intrinsic sympathomimetic activity on blood pressure and blood lipids in patients with essential hypertension].
    Serro-Azul JB, Wajngarten M, Santomauro A, Braga A, Yazbek Júnior P, Bellotti G, Serro-Azul LG, Pileggi F.
    Arq Bras Cardiol; 1989 Dec; 53(6):321-5. PubMed ID: 2700113
    [Abstract] [Full Text] [Related]

  • 13. Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia.
    Insull W, Davidson MH, Kulkarni PM, Siddhanti S, Ciaccia AV, Keech CA.
    Metabolism; 2005 Jul; 54(7):939-46. PubMed ID: 15988705
    [Abstract] [Full Text] [Related]

  • 14. [Behavior of high-density lipoproteins in drug lipid-lowering treatment].
    Mordasini R, Riesen W, Oster P, Riva G.
    Schweiz Med Wochenschr; 1982 Jan 16; 112(3):95-8. PubMed ID: 7058319
    [Abstract] [Full Text] [Related]

  • 15. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
    Spence JD, Huff M, Barnett PA.
    Can J Clin Pharmacol; 2000 Jan 16; 7(1):32-7. PubMed ID: 10822211
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major.
    Al-Quobaili FA, Abou Asali IE.
    Saudi Med J; 2004 Jul 16; 25(7):871-5. PubMed ID: 15235691
    [Abstract] [Full Text] [Related]

  • 17. Lipid profile in 100 men with moderate hypertension treated for 1 year with atenolol or hydrochlorothiazide plus amiloride: a double-blind, randomized study.
    Otterstad JE, Froeland G, Soeyland AK, Illingworth JM.
    Scand J Clin Lab Invest; 1992 Apr 16; 52(2):83-93. PubMed ID: 1589701
    [Abstract] [Full Text] [Related]

  • 18. Effect of isradipine, a new calcium antagonist on the lipid profile in patients with hypertension.
    Samuel P.
    Cor Vasa; 1990 Apr 16; 32(2 Suppl 1):35-41. PubMed ID: 2143459
    [Abstract] [Full Text] [Related]

  • 19. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A, Freiberg JJ, Nordestgaard BG.
    Circulation; 2008 Nov 11; 118(20):2047-56. PubMed ID: 18955664
    [Abstract] [Full Text] [Related]

  • 20. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J, Chanu B, Bakir R, Sauvanet JP.
    J Pharmacol; 1983 Nov 11; 14 Suppl 2():183-99. PubMed ID: 6138467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.